peptide 1 glp 1 receptor agonist Glucagon-like peptide-1 receptor: mechanisms and advances in therapy 𝗧𝗵𝗲 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗥𝗲𝗰𝗲𝗽𝘁𝗼𝗿

, Teladoc Health member Learn how GLP-1s can help you reach your goals Explore educational resources that help you understand how GLP-1 medications work

the active ingredient is tirzepatide, marketed by Eli Lilly

Rousson V, Allignol A, Aurousseau A, et al

Lancet 368 (9548), 16961705

Conclusion The GLP-1 RAs in people with obesity or type 2 diabetes are associated with a significant reduction in all-cause death, alongside an increased risk of pancreatic adverse eventsparticularly acute pancreatitismost pronounced during the first 6 months of treatment

All authors have reviewed the submitted version and agreed to publish the manuscript